Neutrophil granulocytes, a type of immune cell, are indispensable for the defense against pathogens. However, if they migrate into injured tissue, for example into the brain after a stroke, they can ...

Triple-negative breast cancer (TNBC) is one of the most aggressive and difficult-to-treat forms of breast cancer, lacking targeted therapies due to its molecular characteristics. Tumor-associated ...

Dr. Won Jin Ho presented a talk as part of the Immunology Neighborhood Seminar on “Overcoming the tumor immune ...

Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...

19, 2024 — A study provides insights into the diversity of cancer-associated fibroblasts in white and black skin cancer and describes their different immunomodulatory roles in the tumor environment.

This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...

In an advisory issued Friday, Surgeon General Vivek Murthy recommended that labels on alcoholic beverages be updated to include a warning about the risk of cancer associated with alcohol ...

Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX® ) and mFOLFOX6 ...

Treatment with bezuclastinib plus Sutent led to safe and efficacious outcomes versus Sutent treatment alone in gastrointestinal stromal tumors.

These targets are carefully selected based on their expression on CRC cells and minimal presence on normal tissues to reduce off-tumor toxicity. 21 Here, we discuss several key targets for CAR-T cell ...

There are several types of thyroid cancer, each originating in a different type of thyroid cell. The overgrowth occurs due to hereditary or acquired mutations (genetic changes). Risk factors ...